Skip to main content
Earnings Labs
Sangamo Therapeutics, Inc. logo

Sangamo Therapeutics, Inc. (SGMO)

NASDAQ·Healthcare·Biotechnology

$0.18

Mkt Cap $87.00M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (4 analysts)

$7.25

Range $2.00$19.00

Implied Upside

+3892.3%

Consensus $7.25 vs current $0.18